Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in QGEN — Qiagen N.V.

CIK 1387508 NEW YORK, NY

Position in QGEN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$405,364
+$142,093 QoQ
Shares Held
10,124
+63.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in QGEN Over Time

Shares Held

Position Value (USD)

Derivatives in QGEN

reported options exposure · as of Mar 31, 2020
CallValue
$38,637
CallShares
900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $11,334,331 across 9 Diagnostics & Research names.

# Ticker Company Shares Value (USD) Open

All Filings in QGEN

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $405,364 10,124
2022-09-30 $263,271 6,180
2022-06-30 $1,116,092 22,913
2021-12-31 $300,785 5,244
2021-03-31 $296,009 5,891
2020-09-30 $6,849 127
2020-06-30 $320,699 7,259
2020-03-31 $38,637 900